Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) EBIT Margin (2019 - 2025)

Outset Medical (OM) has disclosed EBIT Margin for 7 consecutive years, with 111.1% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 18529.0% to 111.1% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.23%, a 8550.0% increase, with the full-year FY2025 number at 14.23%, up 8550.0% from a year prior.
  • EBIT Margin was 111.1% for Q4 2025 at Outset Medical, up from 53.73% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 111.1% in Q4 2025 to a low of 174.49% in Q2 2022.
  • A 5-year average of 102.42% and a median of 120.02% in 2022 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: plummeted -5589bps in 2022, then soared 18529bps in 2025.
  • Outset Medical's EBIT Margin stood at 144.92% in 2021, then rose by 14bps to 124.42% in 2022, then increased by 2bps to 122.44% in 2023, then skyrocketed by 39bps to 74.18% in 2024, then surged by 250bps to 111.1% in 2025.
  • Per Business Quant, the three most recent readings for OM's EBIT Margin are 111.1% (Q4 2025), 53.73% (Q3 2025), and 53.68% (Q2 2025).